Basit öğe kaydını göster

dc.contributor.authorGÜLBAHÇE MUTLU, Elif
dc.contributor.authorBALTACI, Saltuk Buğra
dc.date.accessioned2021-01-22T08:38:32Z
dc.date.available2021-01-22T08:38:32Z
dc.date.issued2020
dc.identifier.urihttp://hdl.handle.net/20.500.12498/4972
dc.description.abstractBACKGROUND: This study aims to investigate the effects of zinc and melatonin supplementation on lipid peroxidation in the brain cortex in DMBA-induced breast cancer in female rats. METHODS: A total of 42 recently weaned Wistar rats were divided into 5 groups as follows: Control (Group 1), DMBA Control (Group 2), DMBA+Zinc (Group 3), DMBA+Melatonin (Group 4), DMBA+Melatonin & Zinc (Group 5). At the end of the study, all animals were sacrifi ced by decapitation and Malondialdehyde (MDA) and glutathione (GSH) levels in brain cortex tissue samples were determined via spectrophotometric methods. RESULTS: The highest MDA levels were in the DMBA-treated group (Group 2) (p < 0.05). MDA levels in Group 3, Group 4, and Group 5 were signifi cantly lower than in group 2 (p < 0.05). Also, GSH levels in group 3, 4, and 5 were signifi cantly higher than in group 2 (p < 0.05). CONCLUSION: There are no reports on whether DMBA-induced experimental breast cancer affects oxidative stress in brain tissue. In this respect, our study revealed that the increased brain cortex tissue damage in DMBA-induced breast cancer is alleviated by Zinc, melatonin, or combined zinc and melatonin treatment (Fig. 3, Ref. 26).en_US
dc.language.isoenen_US
dc.publisherBratisl Med Jen_US
dc.subjectDMBAen_US
dc.subjectBreast Canceren_US
dc.subjectBrain Tissueen_US
dc.subjectMDAen_US
dc.subjectGSHen_US
dc.subjectZincen_US
dc.subjectMelatoninen_US
dc.titleZinc And Melatonin Supplementation Ameliorates Brain Cortex Tissue Damage in Dmba-Induced Breast Cancer İn Ratsen_US
dc.typeMakaleen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster